Elusive Gene Mutations Found for Malignant Brain Tumor
Exercise Associated with Longer Survival After Brain Cancer Diagnosis
Cancer Vaccines: The Quest Continues
Duke Vaccine Extends Survival for Patients with Deadly Brain Cancers
The common interests of the Brain Tumor Research Program are primary malignant brain tumors of adults and children. The scientific goals are to:
Duke continues to lead the nation in having the largest clinical brain tumor service, seeing between 800 and 900 new brain tumor patients annually.